These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 11747450

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. ATP-binding properties of P glycoprotein from multidrug-resistant KB cells.
    Cornwell MM, Tsuruo T, Gottesman MM, Pastan I.
    FASEB J; 1987 Jul; 1(1):51-4. PubMed ID: 2886389
    [Abstract] [Full Text] [Related]

  • 24. The molecular interaction of the high affinity reversal agent XR9576 with P-glycoprotein.
    Martin C, Berridge G, Mistry P, Higgins C, Charlton P, Callaghan R.
    Br J Pharmacol; 1999 Sep; 128(2):403-11. PubMed ID: 10510451
    [Abstract] [Full Text] [Related]

  • 25. Proximity of bound Hoechst 33342 to the ATPase catalytic sites places the drug binding site of P-glycoprotein within the cytoplasmic membrane leaflet.
    Qu Q, Sharom FJ.
    Biochemistry; 2002 Apr 09; 41(14):4744-52. PubMed ID: 11926837
    [Abstract] [Full Text] [Related]

  • 26. The functional purification of P-glycoprotein is dependent on maintenance of a lipid-protein interface.
    Callaghan R, Berridge G, Ferry DR, Higgins CF.
    Biochim Biophys Acta; 1997 Sep 04; 1328(2):109-24. PubMed ID: 9315609
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. FRET analysis indicates that the two ATPase active sites of the P-glycoprotein multidrug transporter are closely associated.
    Qu Q, Sharom FJ.
    Biochemistry; 2001 Feb 06; 40(5):1413-22. PubMed ID: 11170469
    [Abstract] [Full Text] [Related]

  • 29. The homodimeric ATP-binding cassette transporter LmrA mediates multidrug transport by an alternating two-site (two-cylinder engine) mechanism.
    van Veen HW, Margolles A, Müller M, Higgins CF, Konings WN.
    EMBO J; 2000 Jun 01; 19(11):2503-14. PubMed ID: 10835349
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Combined mutation of catalytic glutamate residues in the two nucleotide binding domains of P-glycoprotein generates a conformation that binds ATP and ADP tightly.
    Tombline G, Bartholomew LA, Urbatsch IL, Senior AE.
    J Biol Chem; 2004 Jul 23; 279(30):31212-20. PubMed ID: 15159388
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Functional analysis of P-glycoprotein mutants identifies predicted transmembrane domain 11 as a putative drug binding site.
    Kajiji S, Talbot F, Grizzuti K, Van Dyke-Phillips V, Agresti M, Safa AR, Gros P.
    Biochemistry; 1993 Apr 27; 32(16):4185-94. PubMed ID: 7682843
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Nucleotide binding, ATP hydrolysis, and mutation of the catalytic carboxylates of human P-glycoprotein cause distinct conformational changes in the transmembrane segments.
    Loo TW, Bartlett MC, Clarke DM.
    Biochemistry; 2007 Aug 14; 46(32):9328-36. PubMed ID: 17636884
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.